11/25/2021 | Press release | Distributed by Public on 11/25/2021 13:03
25 Nov 2021 20:00 CET
NORDHEALTH AS A-AKSJER
NO0011002651
Euronext Growth
NORDH
Helsinki, Finland, 25 November 2021: Nordhealth will report and present its Q3
2021 results on Tuesday the 30th of November 2021. The results will be presented
in a live presentation and subsequent Q&A session with CEO Charles MacBain and
CFO Valter Pasanen on the 30th of November at 08:00 am CET.
Please use the following link: https://us02web.zoom.us/j/81859813187
The presentation will be recorded and made available on www.nordhealth.com
The presentation material and the interim report for Q3 will be available at
07:30 am CET on www.newsweb.no and on Nordhealth's IR
website https://nordhealth.com/investor/news-and-documents/
About Nordhealth
Nordhealth is a publicly listed and fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 30,000 veterinary
and therapy professionals across 7,000 clinics and hospitals located in over 25
countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 240
employees working either remotely or from offices (collaboration hubs). For more
details visit the company's website at nordhealth.com.
More information:
Access the news on Oslo Bors NewsWeb site
Nordhealth AS
Oslo Børs Newspoint